Evidence map›Paper›PMID 38741213›Full record

ArticleJournal of health, population, and nutrition2024

Global research trend and hotspot in the low FODMAP diet: a bibliometric analysis.

Cheng Xu, Zhen Song, Jing-Yi Hu, Chong-Chao Li, Hong Shen

Abstract read
In one paragraph

Article in Journal of health, population, and nutrition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Cheng XuAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Zhen SongNanjing University of Chinese Medicine, Nanjing, China.
Jing-Yi HuAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
Chong-Chao LiNanjing University of Chinese Medicine, Nanjing, China.
Hong ShenAffiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China. shenhong999@njucm.edu.cn.

Funding

Jiangsu Province Traditional Chinese medicine digestive disease medical innovation center CXZX202208
6 · The paper itself

Abstract

backgroundAccording to national guidelines, a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) is a second-line therapy option for irritable bowel syndrome (IBS) and improves functional intestinal symptoms. Numerous noteworthy results have been published in this field over the past fifteen years. This study aims to analyze the global research trend and hotspot of the low FODMAP diet research, and provide a comprehensive perspective and direction for researchers.

methodsThe Science Citation Index-Expanded of the Web of Science Core Collection (WoSCC) was used to identify low FODMAP diet-related articles and reviews. Three bibliometric programs (CiteSpace, VOSviewer, Scimago Graphic) were utilized to analyze and visualize the annual publications, authors, countries, institutions, journals, citations, and keywords.

resultsIn total, 843 documents related to the low FODMAP diet research were published in 227 journals by 3,343 authors in 1,233 institutions from 59 countries. The United States, which was the most engaged nation in international collaboration, had the largest annual production and the fastest growth. The most productive organization was Monash University, and the most fruitful researcher was Gibson PR. Nutrients ranked first in terms of the number of published documents. The article "A diet low in FODMAPs reduces symptoms of irritable bowel syndrome" (Halmos EP, 2014) received the most co-citations. Keywords that appear frequently in the literature mainly involve two main aspects: the clinical efficacy evaluation and mechanism exploration of the low FODMAP diet. The term "gut microbiota" stands out as the most prominent keyword among the burst keywords that have remained prevalent till date.

conclusionThe restriction stage of the low FODMAP diet is superior to other dietary therapies for IBS in terms of symptom response, but it has a negative impact on the abundance of gut Bifidobacteria and diet quality. Identification of biomarkers to predict response to the low FODMAP diet is of great interest and has become the current research hotspot.

Indexed as

BibliometricsFODMAP DietIrritable Bowel SyndromeOligosaccharidesBiomedical ResearchDisaccharidesFermentationHumansMonosaccharidesPolymersDisaccharidesMonosaccharidesOligosaccharidesPolymerspolyolBibliometric analysisDietary management strategyFODMAPHotspotsIrritable bowel syndromeLow FODMAP diet

Identifiers

PMID38741213
PMCPMC11092139

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.